InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: hschlauch post# 42611

Monday, 12/18/2017 11:34:48 PM

Monday, December 18, 2017 11:34:48 PM

Post# of 48316
Regarding the article published a few days ago, Algazi mentioned starting a new study for Head and Neck cancer based on the positive data presented at SITC. I would assume it would follow the same protocol as the PISCES trial...and Merck providing Keytruda. Wondering if this time Merck provides upfront cash.